Target intelligence / Profile preview

RNA, U1 small nuclear 58, pseudogene (RNU1-58P)

Target: RNU1-58P
Molecular classification: Other (Pseudogene, small nuclear RNA pseudogene)

Overview

RNA, U1 small nuclear 58, pseudogene (RNU1-58P) is a human genomic pseudogene associated with the U1 small nuclear RNA family. Unlike functional snRNAs like U1, which are essential components of the spliceosome and play critical roles in pre-mRNA splicing, RNU1-58P is classified as a pseudogene—meaning it does not produce an active RNA or protein and is not involved in cellular regulatory functions. As such, it does not serve as a therapeutic target, and there is no evidence linking RNU1-58P to disease, drug interactions, or biomarker status.

Other names: RNU1-58P

Mechanism of action

None. No known mechanisms of action for this pseudogene

Biological functions

None directly; pseudogenes generally do not have an active biological function by definition. Functional U1 snRNAs are involved in pre-mRNA splicing, but pseudogenes do not contribute directly to this process.

Disease associations

None established. No direct role in disease for RNU1-58P. (By contrast, some snRNA variants or disruptions may affect splicing patterns and cellular regulation, but no current evidence for RNU1-58P.)

Safety considerations

None. No therapeutic relevance or safety data

Interacting drugs

None. There are no drugs that target RNU1-58P, as it does not have protein or catalytic activity

Biomarkers

None known for patient selection or efficacy monitoring

Beyond the preview

Go deeper on RNA, U1 small nuclear 58, pseudogene (RNU1-58P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 58, pseudogene (RNU1-58P).

Explore the full profile